Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

OSIR

Osiris Therapeutics, Inc. (OSIR)

Osiris Therape (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OSIR
DataHoraFonteTítuloCódigoCompanhia
29/04/201917:13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OSIROsiris Therape (MM)
17/04/201910:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:OSIROsiris Therape (MM)
17/04/201910:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
17/04/201910:19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201910:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
17/04/201910:05GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plcNASDAQ:OSIROsiris Therape (MM)
17/04/201907:08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
17/04/201907:08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
20/03/201908:43Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OSIROsiris Therape (MM)
20/03/201908:33Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OSIROsiris Therape (MM)
15/03/201919:13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
15/03/201910:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSIROsiris Therape (MM)
12/03/201918:10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
12/03/201918:03Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OSIROsiris Therape (MM)
12/03/201914:14PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
12/03/201910:33PR Newswire (US)Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
12/03/201910:00GlobeNewswire Inc.Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plcNASDAQ:OSIROsiris Therape (MM)
28/02/201911:00GlobeNewswire Inc.Predictive Technology Group Names Jay M. Moyes to Its Board of DirectorsNASDAQ:OSIROsiris Therape (MM)
29/11/201819:24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OSIROsiris Therape (MM)
26/11/201819:30GlobeNewswire Inc.Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive OfficerNASDAQ:OSIROsiris Therape (MM)
07/11/201819:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OSIROsiris Therape (MM)
07/11/201819:15GlobeNewswire Inc.Osiris Therapeutics, Inc Reports Third Quarter 2018 ResultsNASDAQ:OSIROsiris Therape (MM)
30/10/201817:30GlobeNewswire Inc.Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fa...NASDAQ:OSIROsiris Therape (MM)
02/10/201817:30GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living ...NASDAQ:OSIROsiris Therape (MM)
17/09/201818:00GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018NASDAQ:OSIROsiris Therape (MM)
27/08/201817:30GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Comparing the Efficacy of Viable Cryopreserved Placental Membra...NASDAQ:OSIROsiris Therape (MM)
31/07/201811:33Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:OSIROsiris Therape (MM)
27/07/201817:05Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:OSIROsiris Therape (MM)
25/07/201817:33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSIROsiris Therape (MM)
11/05/201815:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OSIROsiris Therape (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:OSIR